Page last updated: 2024-09-04

yh 439 and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide

yh 439 has been researched along with 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide in 1 studies

Compound Research Comparison

Studies
(yh 439)
Trials
(yh 439)
Recent Studies (post-2010)
(yh 439)
Studies
(7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide)
Trials
(7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide)
Recent Studies (post-2010) (7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide)
21021,2016149

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, JW; Shlyankevich, M; Surh, YJ; Yoo, JK1

Other Studies

1 other study(ies) available for yh 439 and 7,8-dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide

ArticleYear
Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
    Mutation research, 1996, Apr-06, Volume: 367, Issue:4

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Animals; Anticarcinogenic Agents; Antimutagenic Agents; Benzo(a)pyrene; Biotransformation; DNA; DNA Adducts; Liver; Microsomes, Liver; Molecular Structure; Mutagenicity Tests; Mutagens; Rats; Rats, Sprague-Dawley; Salmonella typhimurium; Thiazoles

1996